How the endocytic network mediates specificity of cell signaling
How the endocytic network mediates specificity of cell signaling
批准号:
10623603
负责人:
Yan Yu
金额:
$51.09万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-08-15 至 2028-08-31
关键词:
AddressAutoimmune DiseasesBiological ProcessCOVID-19Cancer VaccinesCardiovascular DiseasesCell NucleusCell membraneCell physiologyCellsChemicalsCommunicable DiseasesComputer ModelsCuesDevelopmentDiseaseEndocytosisEndosomesFeedbackFoundationsFunctional disorderGoalsImmunologic AdjuvantsInflammatory ResponseKnowledgeLengthMalignant NeoplasmsMediatingMissionModelingOrganellesPathogenesisPlayPreventionPublic HealthReceptor Cross-TalkReportingResearchRoleSignal TransductionSortingSpecificityStimulusUnited States National Institutes of Healthcancer therapycombinatorialdisease diagnosisendosome membraneexperimental studyextracellularhuman diseasenovelnovel strategiesnovel therapeutic interventionreceptorresponsespatiotemporal
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract: How the endocytic network mediates specificity of cell signaling
Receptor crosstalk – the cooperation between two or more receptors to modulate cell responses – is a key
signaling mechanism. It enables cells to generate a large combinatorial repertoire of specific signaling with a
limited variety of receptors. Receptor crosstalk plays an essential role in cell physiology. Consequently,
dysfunctions in receptor crosstalk are associated with many human diseases, such as infectious diseases
(including COVID-19), cancer, and cardiovascular diseases. To understand the physical mechanisms by which
signals from different receptors are integrated in crosstalk, studies have exclusively focused on receptor
interactions at the plasma membrane. In contrast, how the crosstalk signals are transduced with high fidelity
from the plasma membrane to the nucleus is poorly understood and scarcely explored.
The overall goal of this research is to establish the functional role of the endocytic network in transducing and
regulating receptor crosstalk. Under the prior ESI-R35 support, our group has made pioneering discoveries
in support of the central hypothesis that the endocytic network is where extracellular chemical and
physical stimuli intertwine to regulate receptor crosstalk. Specifically, we reported a new model in which
receptors can crosstalk by forming overlapping interfaces between discrete signaling clusters, challenging the
prevailing view that receptors oligomerize to crosstalk. Importantly, such spatially organized interaction between
receptors at endosomes and plasma membranes is modulated by extracellular physical cues, and directly
regulates cell inflammatory responses. These prior discoveries and the plethora of new approaches we
developed for studying endosome functions laid a critical and unique foundation for us to address the
knowledge gap: how does the endocytic network mediate receptor crosstalk? We will address how the
endocytic network orchestrates chemical cues from receptor crosstalk (Direction 1), and transduces
extracellular physical cues to refine the specificity of crosstalk signaling (Direction 2). To address the first
direction, we will define the physical mechanisms by which endocytic sorting, collective endosome-organelle
interactions, and endosome-specific activation modulate crosstalk signaling originated from the plasma
membrane. To address the second direction, we will integrate experiments with computational modeling to
determine the feedback loop between the endocytic network and cell-matrix interactions that regulate receptor
crosstalk. This project will establish a mechanistic and predictive understanding of how the endocytic network
mediates the spatiotemporal specificity of receptor crosstalk and cell signaling in general; a topic that is poorly
understood. It will also lower the technical barrier that has impeded research on this topic, by establishing novel
quantitative toolsets for dissecting the dynamics and function of the endocytic network on multiple length scales.
Ultimately, a better understanding of endosome functions in receptor crosstalk will facilitate the development of
new therapeutic strategies for diseases, such as immune adjuvants for cancer therapies and vaccines.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1126/sciadv.abc8482
发表时间:
2020-12
期刊:
Science advances
影响因子:
13.6
作者:
[Li M, Wang H, Li W, Xu XG, Yu Y]
通讯作者:
Yu Y
Anisotropic presentation of ligands on cargos modulates degradative function of phagosomes
货物上配体的各向异性呈现调节吞噬体的降解功能
DOI:
10.1016/j.bpr.2021.100041
发表时间:
2022
期刊:
Biophysical Reports
影响因子:
--
作者:
[Jiao, Mengchi, Li, Wenqian, Yu, Yanqi, Yu, Yan]
通讯作者:
Yu, Yan
DOI:
10.1021/acsnano.9b07445
发表时间:
2019-10-01
期刊:
ACS NANO
影响因子:
17.1
作者:
[Yu,Yanqi, Li,Miao, Yu,Yan]
通讯作者:
Yu,Yan
DOI:
10.1038/s41598-021-92910-9
发表时间:
2021-06-28
期刊:
Scientific reports
影响因子:
4.6
作者:
[Li W, Li M, Anthony SM, Yu Y]
通讯作者:
Yu Y
DOI:
10.1146/annurev-anchem-092822-085852
发表时间:
2023-06
期刊:
Annual review of analytical chemistry (Palo Alto, Calif.)
影响因子:
--
作者:
[Seonik Lee;Mengchi Jiao;Zihan Zhang;Yan Yu]
通讯作者:
Seonik Lee;Mengchi Jiao;Zihan Zhang;Yan Yu
共 9 条
Targeting Lysine-specific Demethylase 1 to Enhance the Post-transplant Graft-versus-leukemia Effect
-
批准号:467033
-
项目类别:Studentship Programs
-
资助金额:$1.27万
-
财政年份:2021
-
负责人:Yan Yu
-
依托单位:
Decoupling Receptor Clusters and Signaling Crosstalk in Phagosome Membranes
-
批准号:9387826
-
项目类别:
-
资助金额:$7.27万
-
财政年份:2017
-
负责人:Yan Yu
-
依托单位:
Unravelling Mechanisms of Endosomal Signaling with Designer Nanomaterials
-
批准号:10172924
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2017
-
负责人:Yan Yu
-
依托单位:
Unravelling Mechanisms of Endosomal Signaling with Designer Nanomaterials
-
批准号:9382294
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2017
-
负责人:Yan Yu
-
依托单位:
Sono-Contrast Induced Functional Imaging/Spectroscopy
-
批准号:7230953
-
项目类别:
-
资助金额:$31.84万
-
财政年份:2004
-
负责人:Yan Yu
-
依托单位:
Sono-Contrast Induced Functional Imaging/Spectroscopy
-
批准号:7341355
-
项目类别:
-
资助金额:$36.55万
-
财政年份:2004
-
负责人:Yan Yu
-
依托单位:
Sono-Contrast Induced Functional Imaging/Spectroscopy
-
批准号:7115008
-
项目类别:
-
资助金额:$2.47万
-
财政年份:2004
-
负责人:Yan Yu
-
依托单位:
Orthogonal ultrasound for cancer detection and therapy
-
批准号:6924608
-
项目类别:
-
资助金额:$4.55万
-
财政年份:2004
-
负责人:Yan Yu
-
依托单位:
Sono-Contrast Induced Functional Imaging/Spectroscopy
-
批准号:7090151
-
项目类别:
-
资助金额:$35.99万
-
财政年份:2004
-
负责人:Yan Yu
-
依托单位:
Orthogonal ultrasound for cancer detection and therapy
-
批准号:7341339
-
项目类别:
-
资助金额:$12.57万
-
财政年份:2004
-
负责人:Yan Yu
-
依托单位:
Orthogonal ultrasound for cancer detection and therapy
-
批准号:6780026
-
项目类别:
-
资助金额:$17.55万
-
财政年份:2004
-
负责人:Yan Yu
-
依托单位:
Sono-Contrast Induced Functional Imaging/Spectroscopy
-
批准号:6783889
-
项目类别:
-
资助金额:$16.82万
-
财政年份:2004
-
负责人:Yan Yu
-
依托单位:
Robot-Assisted Platform for Intratumoral Delivery
-
批准号:7122930
-
项目类别:
-
资助金额:$12.61万
-
财政年份:2003
-
负责人:Yan Yu
-
依托单位:
Robot-Assisted Platform for Intratumoral Delivery
-
批准号:6802281
-
项目类别:
-
资助金额:$61.7万
-
财政年份:2003
-
负责人:Yan Yu
-
依托单位:
Robot-Assisted Platform for Intratumoral Delivery
-
批准号:7341053
-
项目类别:
-
资助金额:$43.05万
-
财政年份:2003
-
负责人:Yan Yu
-
依托单位:
Robot-Assisted Platform for Intratumoral Delivery
-
批准号:6648150
-
项目类别:
-
资助金额:$42.64万
-
财政年份:2003
-
负责人:Yan Yu
-
依托单位:
Robot-Assisted Platform for Intratumoral Delivery
-
批准号:6944230
-
项目类别:
-
资助金额:$48.25万
-
财政年份:2003
-
负责人:Yan Yu
-
依托单位:
Robot-Assisted Platform for Intratumoral Delivery
-
批准号:7245907
-
项目类别:
-
资助金额:$47.76万
-
财政年份:2003
-
负责人:Yan Yu
-
依托单位:
PIPER: PROSTATE IMPLANT PLANNING ENGINE FOR RADIOTHERAPY
-
批准号:6021304
-
项目类别:
-
资助金额:$29.12万
-
财政年份:1998
-
负责人:Yan Yu
-
依托单位:
PIPER PROSTATE IMPLANT PLANNING ENGINE FOR RADIOTHERAPY
-
批准号:2651914
-
项目类别:
-
资助金额:$9.88万
-
财政年份:1998
-
负责人:Yan Yu
-
依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
-
批准号:31171277
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:Christine Nardini
-
依托单位: